News
We bring you up to date at all times: Discover the latest news from the chemical industry, analytics, lab technology and process engineering. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of the chemical industry: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 64,557 keywords from chemistry, pharmaceutics, material sciences and related science disciplines in the encyclopedia.
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.chemeurope.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
17-Feb-2006 - PLIVA d.d. announced that an agreement has been signed with Novartis' generics division, Sandoz, for the purchase of its Spanish subsidiary Uso Racional S.L (UR) for a total cash consideration of EUR 21.5m. With expected sales of about EUR 12m in 2006, UR represents a well known and established ...
16-Feb-2006 - PLIVA d.d. announced a deal in which it has reached agreement with GlaxoSmithKline (GSK) for the purchase of PLIVA - Istrazivaki Institut d.o.o. (PLIVA - Research Institute Ltd.), PLIVA's proprietary R&D arm renowned for its research into macrolides, in Zagreb, Croatia. In May 2005, PLIVA ...
30-Jan-2006 - PLIVA d.d. announced today that its German subsidiary AWD.pharma GmbH & Co. KG signed an agreement with the Menarini Group of Italy, for the divestment of its manufacturing plant in Dresden, Germany. The sale of the German facility reflects a key step in the process of optimizing PLIVA's ...
22-Nov-2005 - PLIVA d.d. announced that its partner on ondansetron hydrochloride (HCl) orally disintegrating tablets (ODT) in 4 mg and 8 mg strengths, Kali Laboratories, Inc. ("Kali"), a whollyowned subsidiary of Par Pharmaceutical Companies, Inc., has received final approval from the U.S. Food and Drug ...
10-Nov-2005 - PLIVA d.d. announced that it has completed the divestment of VoSpire of its US branded subsidiary Odyssey Pharmaceuticals Inc., to DAVA Pharmaceuticals Inc., (DAVA) a privately held specialty pharmaceutical company. PLIVA received a total payment of USD 32m for the transaction upon closing as ...
08-Nov-2005 - PLIVA d.d. announced that PLIVA Inc., its US generics subsidiary, has received final approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for Citalopram Hydrobromide Tablets 10 mg, 20 mg, and 40 mg. Citalopram Hydrobromide is the AB-rated ...
05-Oct-2005 - PLIVA d.d. announced that, on 30 September 2005, it terminated its agreements with Canada-based Legacy Pharma Limited Partnership ("Legacy") for the sale of the CNS franchise of Odyssey Pharmaceuticals Inc. ("Odyssey"), PLIVA's US specialty branded pharmaceuticals subsidiary, due to Legacy's ...
30-Sep-2005 - PLIVA d.d. announced that it has entered into an agreement with Dava Pharmaceuticals Inc., a privately held specialty pharmaceutical company, for the sale of VoSpire ER of Odyssey Pharmaceuticals Inc., PLIVA's US specialty branded pharmaceuticals subsidiary, for a total potential cash ...
06-Jul-2005 - PLIVA d.d. announced that it has completed the previously announced divestment of SANCTURA of its US branded subsidiary Odyssey Pharmaceuticals Inc. to Esprit Pharma ("Esprit", formerly known as Saturn Pharmaceuticals Inc.). Upon closing, PLIVA received an up-front payment of USD 45m from ...
© 1997-2024 LUMITOS AG, All rights reserved